Ardigen - Cancer Vaccines
From Immunology – TCR Therapies
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell therapies.
-
Most popular related searches
Value We Deliver
- AI predictions of functional T-cell responses
- Evasion of off-target immunotoxicity
- Providing help of CD4+ T-cells
- Selecting clonal epitopes
- Detecting immune escape mechanisms
- Designing off-the-shelf or personalized cancer vaccines
ArdImmune Vax Platform key functionalities to augm...
ArdImmune Vax Platform key functionalities to augment therapy development
The platform consists of bioinformatics and machine learning algorithms that generate putative antigens, determine patients’ MHCs, predict antigen(peptide)-MHC binding affinity, the likelihood of the peptide presentation by the MHC molecules, and the probability of pMHC attracting T-cells to generate functional responses described as immunogenicity.
Customer reviews
No reviews were found for Ardigen - Cancer Vaccines. Be the first to review!